Research And Development Tenders

Medicines with the Active Ingredient Fampridine (Atc: N07xx07)

Medicines with the Active Ingredient Dupilumab (Atc: D11ah05)

Medicines with the Active Ingredient Tiotropium Bromide (Atc: R03bb04 - Except in the Dosage Form Hard Capsules with Powder for Inhalation)

Delivery of Rail Chamber Elements for Rail Shapes Ri 53-10, 49E1, 60R1, 60R2, 55R1, 59R1 and 59R2 as Well as Rail Foot Pads Made from Recyclable Materials

Open House Drug Discount Agreements Calcipotriol and Betamethasone, Excluding Ointments, Atc D05ax22

Open House Drug Discount Agreements Lamivudine, Tenofovir Disoproxil and Doravirine, Atc J05ar24

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Tiotropium Olodaterol, Atc R03al06 for the Period June 1St, 2024 - May 31St, 2026

Open House Drug Discount Agreements Alitretinoin, Atc D11ah04

Open House Drug Discount Agreements Interferon Beta-1A, Finished Drug Name Avonex, Atc L03ab07

Open House Drug Discount Agreements Doravirine, Atc J05ag06